Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Presented at American Society of Hematology Annu...( BETHESDA Md. Dec. 3 /- Micromet Inc.(...),Health
Navigation Links
Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Presented at American Society of Hematology Annual Meeting
Date:12/3/2008
BETHESDA, Md., Dec. 3 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, will host a webcast and conference call on, Monday, December 8, 2008, at 2:00 p.m. Eastern Time (8:00 p.m. Central European Time) to discuss the blinatumomab data that were presented at the American Society of Hematology (ASH) meeting.
To access the webcast and view the PowerPoint presentation, please log on to: http://webcasts.micromet-inc.com. To participate in the conference call, dial 866-700-7441 (U.S.) or 617-213-8839 (international), passcode: 39298646.
A replay of the call will be available from 4:00 p.m. Eastern Time on December 8, 2008 (10:00 p.m. Central European Time) through Monday, December 22, 2008. The replay number is 888-286-8010 (U.S.) or 617-801-6888 (international), passcode: 27748310.
About Micromet, Inc.
Micromet, Inc. (www.micromet-inc.com) is a biopharmaceutical company with
offices in Bethesda, Maryland and Munich, Germany. The Company is developing
novel, proprietary antibodies for the treatment of cancer, inflammation and
autoimmune diseases. The Company uses its proprietary BiTE(R) antibody
platform to create a new class of antibodies that specifically activate T
cells from the patient's own immune system to eliminate cancer cells or other
disease-related cells. Four of the Company's antibodies are currently in
clinical trials, with the remainder of its product pipeline in preclinical
development. The Company's lead program is a BiTE antibody known as
blinatumomab, or MT103. It is in a phase 2 clinical trial for the treatment of
patients
'/>"/>
| SOURCE Micromet, Inc. Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Micromet, Inc. Reports Second Quarter 2008 Financial Results
2. Micromet, Inc. Reports First Quarter 2008 Financial Results
3. Gen-Probe to Webcast Presentation at the 20th Annual Piper Jaffray Health Care Conference
4. Covance Inc. Invites You to Join the Webcast of Its 2009 Guidance Conference Call
5. Labopharm to host webcast presentation on novel trazodone formulation for treatment of major depressive disorder
6. Volcano Corporation Presentation at Piper Jaffray Conference to Be Webcast
7. Thoratec Presentation at Piper Jaffary Conference to be Webcast
8. DiagnoCure to webcast presentation at the Piper Jaffray Health Care Conference on December 3, 2008
9. Medco to Webcast 2008 Analyst Day Conference
10. Leading Physicians To Host Medical Device Related Infection Prevention CME Webcast
11. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2008 Third Quarter Results
Post Your Comments:
(Date:11/27/2009)...ll/--TheGymboreeCorporation(Nasdaq: GYMB )announce...X23rdInvestorProgram,whichwillbeheldattheMayFairHo...1:45a.m.GMT. ,, TolistentoalivebroadcastofTheGy...aselogontowww.gymboree.com,clickon"OurCompany"atth...dthen"ConferenceCalls&Webcasts."Thewebcastwill...
(Date:11/27/2009)... may reduce future disease burden, researchers say... Encouraging city dwellers to walk and bicycle ins... health benefits than increased used of low-emissi... study compared the projected health effects in 20...or London, England, and Delhi, India: business-as...
(Date:11/27/2009)...rers who use medical load cells at the heart of th...nging in technology partner Flintec early in the d...dical manufacturers are calling in Flintec load ce... ensuring that progress will not be constrained by... technology. , (PRWEB) No...
(Date:11/26/2009)...ate (TM) has been shown in studies to be effective...sed by an overload of copper, and certain metastat...er, is known about how the drug works at the molec...iversity researchers now has provided an invaluabl...d to copper-loaded metallochaperones. The drug seq...
(Date:11/26/2009)...ntal (RTDental), a leading dental group practice i...nsion of its services to include LUMINEERS by a ce..., Durham, NC (PRWEB) -- Re... Dr. Doug Macmillan, an experienced LUMINEERS De...raining seminar. RTDental’s ability to fulf...
Breaking Medicine News(10 mins):Health News:More Foot Power, Less Car Pollution Best for Health 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2[0] The Gymboree Corporation to Present at NASDAQ OMX 23rd Investor Program[0] More Foot Power, Less Car Pollution Best for Health[0] Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells[1] Research sheds light on workings of anti-cancer drug[0] Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental
... Medicines Safely, WASHINGTON, July 29 The Natio...dministration to issue a guidance for a,combined a...ive their,prescription drugs. In a petition filed ...y Pharmacists,Association, the National Alliance f...
...ark on the brain, by changing patterns of brain ac...nd problems with attention. For one in six America...adder contractions that often trigger more frequen...ow an abnormal organ affects the whole organism," ...
...s to affect memory, concentration, study finds, , ... undergoing hormone deprivation therapy to keep pr...d have trouble concentrating, a new study finds. ,...he level of testosterone, the treatment helps to s...
...nificant and substantial, and calls for ....J., July 29 Eric Svenson, PSEG,s,vice president ... before,Congress about the implications of a recen...e resulted in dramatic reductions,in particulate m...
...po Casa Saba,S.A.B. de C.V. (SAB) announces the pa...Mr. Isaac Saba Raffoul, this past Sunday, July 27,...e deeply sorry for the loss and,extend their most ...hard work and his commitment to both the company,a...
...chers at the 115th,Annual Convention of the Americ...chronic stress can intensify inflammation and incr...s system infections, neurodegenerative,diseases, a...oblems, job loss, poor,diet, and environmental pol...
Other Medicine News:Health News:Consumer and Healthcare Groups Call for Clear, Concise Single Document From Pharmacy 2Health News:Findings on bladder-brain link may point to better treatments for problems in sleep, attention 2Health News:Prostate Cancer Treatment Could Impair Men's Thinking 2Health News:Prostate Cancer Treatment Could Impair Men's Thinking 3Health News:PSEG Supports Quick Congressional Action on Clean Air in Wake of Court's Rescinding of CAIR 2Health News:New Research Shows Chronic Stress Worsens Neurodegenerative and Inflammatory Illnesses 2Consumer and Healthcare Groups Call for Clear, Concise Single Document From PharmacyFindings on bladder-brain link may point to better treatments for problems in sleep, attentionProstate Cancer Treatment Could Impair Men's ThinkingPSEG Supports Quick Congressional Action on Clean Air in Wake of Court's Rescinding of CAIRMr. Isaac Saba Raffoul Passes AwayNew Research Shows Chronic Stress Worsens Neurodegenerative and Inflammatory Illnesses
(Date:11/27/2009)...27/PRNewswire-FirstCall/--Booth-3646/SouthHallA-Va...erofX-raytubesandflatpaneldigitalimagedetectors,wi...tinginChicago,Ill.fromNovember29-December3,2009.Va...iplemodalitiesaswellasspecializedcancertreatmentte...testX-raytechnologyincluding: ,, Abroadarrayof...
(Date:11/25/2009)...,Nov.25/PRNewswire/--PraxisElectronicMedicalRecord...amilyPhysicians,(AAFP)FamilyPracticeManagement(FPM...uality,healthmaintenance,anddiseasemanagement,allc...ked#1amongdoctorsindicatingtheirEMRhadapositiveeff...ednumberoneinthecountryinprovidingexcellenttrainin...
(Date:11/25/2009)...v.25/PRNewswire-FirstCall/--Pharmasset,Inc.(Nasdaq...tedtodiscovering,developingandcommercializingnovel...tsforthefiscalyearendedSeptember30,2009.AtSeptembe...alentsandshortterminvestments. ,, PipelineUpda...bTrial ,, InlateNovember2009,anindependentDat...
Breaking Medicine Technology:Varian Medical Systems to Highlight the Latest Digital Detectors, X-ray Tubes and Cancer Treatment Technology at the Radiological Society of North America (RSNA) Annual Meeting in Chicago 2Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Good Trauma Program Boosts Patient Survival 55023 1Good Trauma Program Boosts Patient Survival 55023 2Chemist+Druggist Reveals Frontline NHS Staff Wont Get Swine Flu Vaccine 13647 1Chemist+Druggist Reveals Frontline NHS Staff Wont Get Swine Flu Vaccine 13647 2Forty two of Simceres Generic Drugs Enter Chinas Essential Drug List 13646 1Forty two of Simceres Generic Drugs Enter Chinas Essential Drug List 13646 2[0] Varian Medical Systems to Highlight the Latest Digital Detectors, X-ray Tubes and Cancer Treatment Technology at the Radiological Society of North America (RSNA) Annual Meeting in Chicago[0] Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey[0] Pharmasset Reports Fiscal Year End 2009 Financial Results
...l Molecular Vision -, - Results Show Good Distrib... after a Single Intravitreal Injection -,...oday announced that a study published in the peer-...t bevasiranib, its siRNA (small,interfering RNA) a...extensive uptake into the retina. In two tissue di...
...ystems, Inc.,(Nasdaq: DCTH ) announced today that...rt of St. Luke,s Hospital & Health Network (St. Lu...l for the treatment of,inoperable metastatic melan...Hepatic Perfusion (PHP) System for the isolated, h...an. This Phase III multi-center,study is led by th...
Other Medicine Technology:Newly Published Study Shows OPKO's siRNA Bevasiranib Is Taken Up by Target Tissues in the Eye 2Newly Published Study Shows OPKO's siRNA Bevasiranib Is Taken Up by Target Tissues in the Eye 3Delcath Expands Phase III Trial for Metastatic Melanoma to Include St. Luke's Cancer Center 2Delcath Expands Phase III Trial for Metastatic Melanoma to Include St. Luke's Cancer Center 3| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |